RecruitingNot applicableNCT05727605

Neurocognition After Radiotherapy in CNS- and Skull-base Tumors

Studying Meningioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universitaire Ziekenhuizen KU Leuven
Principal Investigator
Maarten Lambrecht, MD PhD, MD, PHD
UZ Leuven
Intervention
Neurocognitive tests: WAIS digit span, HVLT-R, COWAT, MOCA, WAIS digit symbol substitution, TMT A&B, Stroop Color Word Test(behavioral)
Enrollment
120 enrolled
Eligibility
18 years · All sexes
Timeline
20232027

Study locations (3)

Collaborators

University Hospital, Ghent · Gasthuis Zusters Antwerpen

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05727605 on ClinicalTrials.gov

Other trials for Meningioma

Additional recruiting or active studies for the same condition.

See all trials for Meningioma

← Back to all trials